| dc.contributor.author | Arslan, S. | |
| dc.contributor.author | Dogan, Z. | |
| dc.contributor.author | Kucukazman, M. | |
| dc.contributor.author | Poyrazoglu, O. K. | |
| dc.contributor.author | Biyik, M. | |
| dc.contributor.author | Ozturk, N. A. | |
| dc.contributor.author | Aydogan, T. | |
| dc.contributor.author | Coban, S. | |
| dc.contributor.author | Kocaman, O. | |
| dc.contributor.author | Sapmaz, F. | |
| dc.contributor.author | Gokturk, S. H. | |
| dc.contributor.author | Demirezer, A. | |
| dc.contributor.author | Tanoglu, A. | |
| dc.contributor.author | Yildirim, B. | |
| dc.contributor.author | Altinbas, A. | |
| dc.contributor.author | Atak, B. M. | |
| dc.contributor.author | Cosar, A. M. | |
| dc.contributor.author | Alkan, E. | |
| dc.contributor.author | KOÇAK TUFAN, ZELİHA | |
| dc.contributor.author | Kekilli, M. | |
| dc.contributor.author | Ataseven, H. | |
| dc.contributor.author | Purnak, T. | |
| dc.contributor.author | Basar, O. | |
| dc.contributor.author | Koklu, N. | |
| dc.contributor.author | Ozturk, O. | |
| dc.contributor.author | Karaca, C. | |
| dc.contributor.author | Besisik, F. | |
| dc.contributor.author | Unverdi, S. | |
| dc.contributor.author | Guner, R. | |
| dc.contributor.author | Bakkaloglu, K. | |
| dc.contributor.author | Koklu, S. | |
| dc.contributor.author | Gulsen, M. T. | |
| dc.contributor.author | Tuna, Y. | |
| dc.contributor.author | Koklu, H. | |
| dc.contributor.author | Yuksel, O. | |
| dc.contributor.author | Demir, M. | |
| dc.contributor.author | Kockar, C. | |
| dc.date.accessioned | 2021-03-05T11:56:53Z | |
| dc.date.available | 2021-03-05T11:56:53Z | |
| dc.date.issued | 2015 | |
| dc.identifier.citation | Koklu S., Gulsen M. T. , Tuna Y., Koklu H., Yuksel O., Demir M., Guner R., Dogan Z., Kucukazman M., Poyrazoglu O. K. , et al., "Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B", ALIMENTARY PHARMACOLOGY & THERAPEUTICS, cilt.41, ss.310-319, 2015 | |
| dc.identifier.issn | 0269-2813 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_aaa927d5-0868-4427-a08c-16f41a5aa1a4 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/113965 | |
| dc.identifier.uri | https://doi.org/10.1111/apt.13036 | |
| dc.description.abstract | BackgroundResults are conflicting with respect to the renal effects of anti-viral agents used for hepatitis B virus infection. | |
| dc.language.iso | eng | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Gastroenteroloji-(Hepatoloji) | |
| dc.subject | Eczacılık | |
| dc.subject | Temel Eczacılık Bilimleri | |
| dc.subject | Yaşam Bilimleri | |
| dc.subject | Temel Bilimler | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Yaşam Bilimleri (LIFE) | |
| dc.subject | Farmakoloji ve Toksikoloji | |
| dc.subject | FARMAKOLOJİ VE ECZACILIK | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | GASTROENTEROLOJİ VE HEPATOLOJİ | |
| dc.title | Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B | |
| dc.type | Makale | |
| dc.relation.journal | ALIMENTARY PHARMACOLOGY & THERAPEUTICS | |
| dc.contributor.department | Hacettepe Üniversitesi , , | |
| dc.identifier.volume | 41 | |
| dc.identifier.issue | 3 | |
| dc.identifier.startpage | 310 | |
| dc.identifier.endpage | 319 | |
| dc.contributor.firstauthorID | 221063 | |
